EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community

Madeline L Wichman, Daniela M Wall, Suzanna S Garcia Mota, Shayna R Killam iD, Karen E Brown, Kaja Aagaard, Juanita Swaney, LeeAnna I Muzquiz, Bernadette N Corum, Katrina G Claw iD, Erica L Woodahl iD

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Madeline L Wichman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Montana, Missoula, Montana, USA. Hauptthemen laut MEDLINE: American Indian or Alaska Native, Pharmacogenetics, Smoking Cessation, Tobacco Use Cessation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application to diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community‐centric study aims to understand perspectives on utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant ( n = 273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of the risks associated with tobacco usage and believed it to be a problem within their community (76%). Our results showed that 29% of participants had some level of knowledge regarding pharmacogenomics and only 6% had previously participated in pharmacogenomics research, demonstrating the need for further education and awareness. Community involvement was a priority for participants, with 64% preferring Tribal inclusion in all research stages and 63% favoring partnerships with local health centers. We also found support for future research, with 68% viewing pharmacogenomics as a beneficial tool. Concerns were raised regarding the handling of genetic material and result dissemination, emphasizing the importance of ethical research practices, transparent communication, and community partnership. Our findings serve as a foundation for shaping future research efforts and developing a framework for implementing tobacco cessation interventions. Our community‐centered approach addresses the specific needs of this AIAN community and offers insights applicable to research practices within other underserved and marginalized populations, particularly those with a historical distrust of research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

American Indian or Alaska NativePharmacogeneticsSmoking CessationTobacco Use CessationAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCommunity ParticipationCommunity-Based Participatory ResearchHealth Knowledge, Attitudes, PracticeSurveys and Questionnaires

Stichwörter der Autor:innen

pharmacogeneticspharmacogenomicsqualitative researchtobacco cessationunderserved communities

Autor:innen und Institutionen

  • Department of Biomedical and Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Montana, Missoula, Montana, USA.
  • L.S. Skaggs Institute for Health Innovation, University of Montana, Missoula, Montana, USA.
  • Environmental Stewardship of Indigenous Lands Certificate Program, University of Colorado Denver, Denver, Colorado, USA.
  • Department of Biomedical Informatics, Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Tribal Health Department, Confederated Salish and Kootenai Tribes, St. Ignatius, Montana, USA.

ORCID-Profile: Shayna R Killam, Katrina G Claw, Erica L Woodahl

Förderung

  • NHGRI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Wichman, M. L., Wall, D. M., Garcia Mota, S. S., Killam, S. R., Brown, K. E., Aagaard, K., Swaney, J., Muzquiz, L. I., Corum, B. N., Claw, K. G., & Woodahl, E. L. (2025). Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community. Clinical and Translational Science. https://doi.org/10.1111/cts.70194

Vancouver

Wichman ML, Wall DM, Garcia Mota SS, Killam SR, Brown KE, Aagaard K, et al. Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community. Clinical and Translational Science. 2025. doi:10.1111/cts.70194

BibTeX
@article{Wichman2025,
  author = {Wichman, Madeline L and Wall, Daniela M and Garcia Mota, Suzanna S and Killam, Shayna R and Brown, Karen E and Aagaard, Kaja and Swaney, Juanita and Muzquiz, LeeAnna I and Corum, Bernadette N and Claw, Katrina G and Woodahl, Erica L},
  title = {Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70194}
}
Kostenlos starten →